Skip to main content
Top
Published in: Endocrine 2/2009

01-04-2009 | Erratum

Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study

Authors: Cihangir Erem, Arif Hacıhasanoglu, Orhan Deger, Murat Topbaş, Ilgın Hosver, Halil Onder Ersoz, Gamze Can

Published in: Endocrine | Issue 2/2009

Login to get access

Excerpt

In Table 1 in the original publication (Endocrine 33(1):9–20), the Parameter subheadings “Men” and “Women” were mistakenly transposed. The data labeled as pertaining to Men apply to Women, and the data labeled as pertaining to Women apply to Men. …
Metadata
Title
Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study
Authors
Cihangir Erem
Arif Hacıhasanoglu
Orhan Deger
Murat Topbaş
Ilgın Hosver
Halil Onder Ersoz
Gamze Can
Publication date
01-04-2009
Publisher
Springer US
Published in
Endocrine / Issue 2/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9147-5

Other articles of this Issue 2/2009

Endocrine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine